464 related articles for article (PubMed ID: 31204558)
1. CircRNA_28313/miR-195a/CSF1 axis modulates osteoclast differentiation to affect OVX-induced bone absorption in mice.
Chen X; Ouyang Z; Shen Y; Liu B; Zhang Q; Wan L; Yin Z; Zhu W; Li S; Peng D
RNA Biol; 2019 Sep; 16(9):1249-1262. PubMed ID: 31204558
[TBL] [Abstract][Full Text] [Related]
2. Overexpressed miR-145 inhibits osteoclastogenesis in RANKL-induced bone marrow-derived macrophages and ovariectomized mice by regulation of Smad3.
Yu FY; Xie CQ; Sun JT; Peng W; Huang XW
Life Sci; 2018 Jun; 202():11-20. PubMed ID: 29577879
[TBL] [Abstract][Full Text] [Related]
3. CircRNA_009934 induces osteoclast bone resorption via silencing miR-5107.
Miao F; Yin BH; Zhang X; Xue DD; Ma C
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7580-7588. PubMed ID: 32744684
[TBL] [Abstract][Full Text] [Related]
4. A circRNA-miRNA-mRNA network plays a role in the protective effect of diosgenin on alveolar bone loss in ovariectomized rats.
Zhang Z; Yue L; Wang Y; Jiang Y; Xiang L; Cheng Y; Ju D; Chen Y
BMC Complement Med Ther; 2020 Jul; 20(1):220. PubMed ID: 32664914
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-338-3p inhibits glucocorticoid-induced osteoclast formation through RANKL targeting.
Zhang XH; Geng GL; Su B; Liang CP; Wang F; Bao JC
Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706599
[TBL] [Abstract][Full Text] [Related]
6. Harmine, a β-carboline alkaloid, inhibits osteoclast differentiation and bone resorption in vitro and in vivo.
Yonezawa T; Hasegawa S; Asai M; Ninomiya T; Sasaki T; Cha BY; Teruya T; Ozawa H; Yagasaki K; Nagai K; Woo JT
Eur J Pharmacol; 2011 Jan; 650(2-3):511-8. PubMed ID: 21047508
[TBL] [Abstract][Full Text] [Related]
7. Pseudogene PTENP1 sponges miR-214 to regulate the expression of PTEN to modulate osteoclast differentiation and attenuate osteoporosis.
Wang CG; Wang L; Yang T; Su SL; Hu YH; Zhong D
Cytotherapy; 2020 Aug; 22(8):412-423. PubMed ID: 32561161
[TBL] [Abstract][Full Text] [Related]
8. Estrogen inhibits osteoclasts formation and bone resorption via microRNA-27a targeting PPARγ and APC.
Guo L; Chen K; Yuan J; Huang P; Xu X; Li C; Qian N; Qi J; Shao Z; Deng L; He C; Xu J
J Cell Physiol; 2018 Jan; 234(1):581-594. PubMed ID: 30272823
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-29a represses osteoclast formation and protects against osteoporosis by regulating PCAF-mediated RANKL and CXCL12.
Lian WS; Ko JY; Chen YS; Ke HJ; Hsieh CK; Kuo CW; Wang SY; Huang BW; Tseng JG; Wang FS
Cell Death Dis; 2019 Sep; 10(10):705. PubMed ID: 31543513
[TBL] [Abstract][Full Text] [Related]
10. Critical role of beta3 integrin in experimental postmenopausal osteoporosis.
Zhao H; Kitaura H; Sands MS; Ross FP; Teitelbaum SL; Novack DV
J Bone Miner Res; 2005 Dec; 20(12):2116-23. PubMed ID: 16294265
[TBL] [Abstract][Full Text] [Related]
11. Identification of circRNA-associated ceRNA network in BMSCs of OVX models for postmenopausal osteoporosis.
Wang H; Zhou K; Xiao F; Huang Z; Xu J; Chen G; Liu Y; Gu H
Sci Rep; 2020 Jul; 10(1):10896. PubMed ID: 32616775
[TBL] [Abstract][Full Text] [Related]
12. Small molecule inhibitor RepSox prevented ovariectomy-induced osteoporosis by suppressing osteoclast differentiation and bone resorption.
Mei L; Sang W; Chen Z; Zheng L; Jin K; Lou C; Huang W; He D
J Cell Physiol; 2018 Dec; 233(12):9724-9738. PubMed ID: 30059597
[TBL] [Abstract][Full Text] [Related]
13. Activation of dimeric glucocorticoid receptors in osteoclast progenitors potentiates RANKL induced mature osteoclast bone resorbing activity.
Conaway HH; Henning P; Lie A; Tuckermann J; Lerner UH
Bone; 2016 Dec; 93():43-54. PubMed ID: 27596806
[TBL] [Abstract][Full Text] [Related]
14. Effects of interleukin-7/interleukin-7 receptor on RANKL-mediated osteoclast differentiation and ovariectomy-induced bone loss by regulating c-Fos/c-Jun pathway.
Zhao JJ; Wu ZF; Yu YH; Wang L; Cheng L
J Cell Physiol; 2018 Sep; 233(9):7182-7194. PubMed ID: 29663382
[TBL] [Abstract][Full Text] [Related]
15. miR-346-3p promotes osteoclastogenesis via inhibiting TRAF3 gene.
Mao Y; Chen Y; Fu Y; Guan J; Liang M; Zhu Y; Yang F; Li F; Zhang Z; Wan C; Zhou P
In Vitro Cell Dev Biol Anim; 2020 Aug; 56(7):533-542. PubMed ID: 32839904
[TBL] [Abstract][Full Text] [Related]
16. Neohesperidin suppresses osteoclast differentiation, bone resorption and ovariectomised-induced osteoporosis in mice.
Tan Z; Cheng J; Liu Q; Zhou L; Kenny J; Wang T; Lin X; Yuan J; Quinn JMW; Tickner J; Hong G; Qin A; Zhao J; Xu J
Mol Cell Endocrinol; 2017 Jan; 439():369-378. PubMed ID: 27664516
[TBL] [Abstract][Full Text] [Related]
17. miR-31 controls osteoclast formation and bone resorption by targeting RhoA.
Mizoguchi F; Murakami Y; Saito T; Miyasaka N; Kohsaka H
Arthritis Res Ther; 2013; 15(5):R102. PubMed ID: 24004633
[TBL] [Abstract][Full Text] [Related]
18. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
19. The miR-1906 mimic attenuates bone loss in osteoporosis by down-regulating the TLR4/MyD88/NF-κB pathway.
Xie H; Cao L; Ye L; Shan G; Song W
Physiol Int; 2021 Nov; 107(4):469-478. PubMed ID: 33410769
[TBL] [Abstract][Full Text] [Related]
20. Glaucocalyxin A suppresses osteoclastogenesis induced by RANKL and osteoporosis induced by ovariectomy by inhibiting the NF-κB and Akt pathways.
Zhu M; Shan J; Xu H; Xia G; Xu Q; Quan K; Liu X; Dai M
J Ethnopharmacol; 2021 Aug; 276():114176. PubMed ID: 33933570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]